Efficacy of linezolid on Treponema pallidum, the syphilis agent: A preclinical study
Open Access
- 1 March 2021
- journal article
- research article
- Published by Elsevier in EBioMedicine
- Vol. 65, 103281
Abstract
No abstract availableKeywords
Funding Information
- European Research Council
This publication has 42 references indexed in Scilit:
- Resistance to Linezolid Caused by Modifications at Its Binding Site on the RibosomeAntimicrobial Agents and Chemotherapy, 2012
- Pharmacokinetic Evaluation of the Penetration of Antituberculosis Agents in Rabbit Pulmonary LesionsAntimicrobial Agents and Chemotherapy, 2012
- A Phase III Equivalence Trial of Azithromycin versus Benzathine Penicillin for Treatment of Early SyphilisThe Journal of Infectious Diseases, 2010
- Quantitative Analysis oftprGene Expression inTreponema pallidumIsolates: Differences among Isolates and Correlation with T-Cell Responsiveness in Experimental SyphilisInfection and Immunity, 2007
- Syphilis Treatment and HIV Infection in a Population-Based Study of Persons at High Risk for Sexually Transmitted Disease/HIV Infection in Lima, PeruSexually Transmitted Diseases, 2006
- A Novel β-Lactamase Activity from a Penicillin-binding Protein of Treponema pallidum and Why Syphilis Is Still Treatable with PenicillinJournal of Biological Chemistry, 2004
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- Efficacy of Ceftizoxime in the Treatment of Incubating Syphilis in RabbitsChemotherapy, 1993
- Clinical Pharmacokinetics of ClofazimineClinical Pharmacokinetics, 1989
- Neurologic Relapse after Benzathine Penicillin Therapy for Secondary Syphilis in a Patient with HIV InfectionNew England Journal of Medicine, 1987